LIVE
WDC$260.94-32.84 (-11.18%)|GOOGL$265.56-8.34 (-3.04%)|INTC$51.34-3.78 (-6.86%)|ORCL$101.11-8.90 (-8.09%)|AMD$423.55-57.50 (-11.95%)|NVO$37.81-1.08 (-2.78%)|JNJ$270.90+4.90 (+1.84%)|NOC$534.11-4.44 (-0.82%)|AVGO$304.02-42.98 (-12.39%)|MRVL$121.89-16.41 (-11.87%)|TSLA$346.25-26.52 (-7.11%)|VST$115.16-6.84 (-5.61%)|VRT$166.15-16.55 (-9.06%)|TSM$319.17-30.93 (-8.83%)|TER$204.52-19.58 (-8.74%)|SMCI$21.66-2.04 (-8.61%)|RCL$296.49-5.81 (-1.92%)|QBTS$6.49-0.82 (-11.22%)|OKLO$20.00+ (+%)|NVDA$125.90-19.77 (-13.57%)|WDC$260.94-32.84 (-11.18%)|GOOGL$265.56-8.34 (-3.04%)|INTC$51.34-3.78 (-6.86%)|ORCL$101.11-8.90 (-8.09%)|AMD$423.55-57.50 (-11.95%)|NVO$37.81-1.08 (-2.78%)|JNJ$270.90+4.90 (+1.84%)|NOC$534.11-4.44 (-0.82%)|AVGO$304.02-42.98 (-12.39%)|MRVL$121.89-16.41 (-11.87%)|TSLA$346.25-26.52 (-7.11%)|VST$115.16-6.84 (-5.61%)|VRT$166.15-16.55 (-9.06%)|TSM$319.17-30.93 (-8.83%)|TER$204.52-19.58 (-8.74%)|SMCI$21.66-2.04 (-8.61%)|RCL$296.49-5.81 (-1.92%)|QBTS$6.49-0.82 (-11.22%)|OKLO$20.00+ (+%)|NVDA$125.90-19.77 (-13.57%)|

Datenschutz & Cookies

Wir nutzen Cookies, um diese Website zu betreiben und zu verbessern. Einige sind technisch notwendig, andere helfen uns, die Nutzung zu verstehen. Du kannst frei wählen, welche du erlaubst. Datenschutz

AktienOctober 23, 20264 min. read

TGIF: Beat Earnings, Lost the Applause – The Lam Research Lesson

Why beating revenue and earnings estimates doesn't guarantee a rising stock.

José Paz | NextSignal

Lam Research beat revenue and adjusted EPS estimates, yet its shares fell. The lesson is about consensus, guidance and expectations already priced in.

The Friday test: Why good numbers aren't always enough

The facts (as of October 23, 2026): On October 21, Lam Research reported $8.22 billion in revenue and $2.20 in adjusted (non-GAAP) EPS for its fiscal Q1 2027, which ended September 27, 2026. FactSet consensus had been approximately $8.14 billion in revenue and $2.18 in adjusted EPS. Both figures therefore slightly exceeded estimates. Reported GAAP EPS was $2.19.

Yet Lam's stock fell sharply on October 22. The Philadelphia Semiconductor Index also dropped approximately 6.7%, according to Reuters. A falling share price does not prove the company delivered a weak quarter: market prices reflect expectations about the future, not just results already achieved.

Two tests, not one

Test 1: Beat consensus. This compares reported numbers with published analyst estimates. Lam passed on revenue and adjusted EPS.

Test 2: Meet the market's forward expectations. For the December quarter, Lam guided to $8.6 billion in revenue ± $0.4 billion and $2.33 in adjusted EPS ± $0.15. These are management forecasts, not reported results. The guidance midpoints were broadly in line with the analyst consensus available at the time. After a strong rally, even solid results can disappoint if investors have priced in faster acceleration.

The October 22 reaction also came amid a broader repricing of AI and semiconductor shares. A single stock move should therefore not be attributed entirely to one earnings report.

The NextSignal takeaway

For earnings season, I look at four layers: Did revenue beat consensus? What happened to margins and cash flow? What does management forecast next? And how much future success is already priced in?

The market doesn't grade only the past. It continually reprices the future. Sometimes a company gets an A — and its stock still gets a red arrow. 😅

Sources: Lam Research, official release October 21, 2026; MT Newswires, consensus October 21, 2026; Reuters, market recap October 22, 2026.

Not financial advice. Investing involves risk.

WHY THIS MATTERS

Beating consensus is only half the test: the market also prices in expectations for the quarters ahead.

NextSignal Assessment

Not every red reaction to good results signals deteriorating fundamentals. Check guidance and expectations already priced in.

Related Stocks

These companies could also benefit from this theme.

#LRCX#Lam Research#Earnings#Halbleiter#AI Infrastructure#Erwartungen
Not investment advice. All content on nextsignal.ch is for informational purposes only and does not constitute investment advice. Investments in securities involve risks.